Nivolumab produces durable responses & long-term survival in severe liver cancer patients
Results from the CheckMate 040 study found that nivolumab, an immuno-oncology drug which acts by…
Browsing: Hepatitis C
How new hepatitis C drugs could tackle liver cancer, too
Maryam Alavi, UNSW and Greg Dore, UNSW Wider availability of newer hepatitis C drugs may…
We could prevent millions of cancer deaths each year with knowledge we already have
David Hunter, Harvard University. Vice President Joe Biden’s Cancer Moonshot Blue Ribbon Panel has released…